Sì, se forniscono valore aggiuntivo rispetto al farmaco, come supporto logistico, viaggi o sistemi di monitoraggio.
Answer to Question 254210
by Ned Mumtaz | Aug 1, 2025
Recent Posts
- Sunshine Act Compliance Dialogue: A Gathering of Industry Leaders & Meaningful Conversations
- Successful Italian Sunshine Report Hands-On Workshop Held in Milan
- A Year in Review: Italian Sunshine Reporting’s Triumphs in 2023
- Italian Sunshine Law Seminar Kicks Off with Resounding Success in Milan
- Your Guides to Italian Sunshine Law: Two Must-Attend Events Revealed